Trinity Biotech (TRIB) Financial Statements

381 Followers

Trinity Biotech Financial Overview

Trinity Biotech's market cap is currently $12.91M. The company's EPS TTM is $-2.01; its P/E ratio is -0.33; Trinity Biotech is scheduled to report earnings on May 27, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Mar 25	Mar 24	Dec 22	Mar 22
Income Statement
Total Revenue	$ 43.92M	$ 61.55M	$ 56.83M	$ 62.52M	$ 81.15M
Gross Profit	$ 15.55M	$ 21.44M	$ 19.45M	$ 22.05M	$ 33.45M
Operating Income	$ -10.96M	$ -21.16M	$ -27.05M	$ -15.27M	$ 3.94M
EBITDA	$ -8.26M	$ -16.91M	$ -24.10M	$ -16.71M	$ 10.59M
Net Income	$ -37.49M	$ -31.79M	$ -24.02M	$ -41.00M	$ 875.00K
Balance Sheet
Cash & Short-Term Investments	$ 5.14M	$ 5.17M	$ 3.69M	$ 6.58M	$ 25.91M
Total Assets	$ 105.17M	$ 103.29M	$ 59.44M	$ 92.10M	$ 118.89M
Total Debt	$ 137.98M	$ 100.76M	$ 67.43M	$ 72.20M	$ 99.16M
Net Debt	$ 132.84M	$ 95.60M	$ 63.74M	$ 51.68M	$ 73.25M
Total Liabilities	$ 177.15M	$ 138.47M	$ 83.38M	$ 94.28M	$ 119.21M
Stockholders' Equity	$ -71.98M	$ -35.18M	$ -23.95M	$ -2.18M	$ -319.00K
Cash Flow
Free Cash Flow	$ -6.34M	$ -14.26M	$ -12.36M	$ -6.90M	$ 4.55M
Operating Cash Flow	$ -6.26M	$ -4.19M	$ -11.56M	$ -921.00K	$ 13.24M
Investing Cash Flow	$ -6.24M	$ -22.97M	$ 24.76M	$ -5.98M	$ -8.69M
Financing Cash Flow	$ 12.40M	$ 28.81M	$ -16.04M	$ -12.32M	$ -6.02M

Currency in USD

Trinity Biotech Earnings and Revenue History

Income Statement >

Trinity Biotech Debt to Assets

Balance Sheet >

Trinity Biotech Cash Flow

Cash Flow >

Trinity Biotech Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >